X
Credit: Castro/Lowenstein Lab
Immunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blue, and H3-G34-mutation in red.
« Unraveling the biology behind aggressive pediatric brain tumor reveals potential new treatment avenue